AstraZeneca removes its Covid vaccine worldwide after rare and dangerous side effect linked to 80 deaths in Britain was admitted in court papers
10 months, 1 week ago

AstraZeneca removes its Covid vaccine worldwide after rare and dangerous side effect linked to 80 deaths in Britain was admitted in court papers

Daily Mail  

AstraZeneca is removing its Covid vaccine worldwide, months after the pharmaceutical giant admitted that it can cause a rare and dangerous side effect. The vaccine, once heralded as a 'triumph for British science', has come under intense scrutiny in recent months for a very rare side effect causing blood clots and low blood platelet counts. The AstraZeneca jab was the most widely used in the UK during the initial rollout of the vaccination programme - before it was linked to a risk in blood clots AstraZeneca admitted in February that the vaccine can, in very rare cases, cause Thrombosis with Thrombocytopenia Syndrome - which has been linked to more than 80 deaths in Britain as well as hundreds of serious injuries. Researchers believe the rare side effect occurs due to the modified cold virus lurking in the jab having an adverse effect on platelets in the blood, triggering clotting The graph shows the cumulative number of Covid jabs dished out in the UK since the pandemic began, the percentage of each age group which has had a jab and the number of each Covid vaccine brand dished out 'As multiple, variant Covid-19 vaccines have since been developed, there is a surplus of available updated vaccines.

Rare Covid Vaccine Effect Jab Astrazeneca Vaxzevria  blood  worldwide  rare  deaths  company  removes  jab  supplied  papers  vaccine  effect  dangerous  covid  linked  astrazeneca  vaxzevria

History of this topic

AstraZeneca scraps plan to expand vaccine plant in the UK in blow to government
1 month, 2 weeks ago

AstraZeneca scraps plan to expand vaccine plant in the UK in blow to government

Associated Press  

LONDON — Pharmaceutical company AstraZeneca on Friday cancelled a planned 450 million-pound investment in a vaccine manufacturing plant in northwest England, blaming the new Labour government for diluting the financial support that had been offered by the previous Conservative administration. In a blow to Treasury chief Rachel Reeves at the end of a week when she trumpeted the government’s plans …

Covishield Side Effects: Doctors' Group Urges Govt to Review All Covid Vaccines
10 months, 1 week ago

Covishield Side Effects: Doctors' Group Urges Govt to Review All Covid Vaccines

News 18  

In the wake of pharmaceutical giant AstraZeneca admitting in a UK court that its Covid vaccine can cause blood clots in rare cases, a group of doctors on Thursday expressed deep concern over the safety of the Covishield vaccine manufactured by the Serum Institute of India. At a press conference, the doctors, under the banner of the Awaken India Movement, …

AstraZeneca withdraws Covishield pointing to low demand, but did rare side effects also play a role?
10 months, 1 week ago

AstraZeneca withdraws Covishield pointing to low demand, but did rare side effects also play a role?

The Hindu  

Published : May 09, 2024 13:21 IST - 3 MINS READ The pharmaceutical giant AstraZeneca has reportedly withdrawn its COVID-19 vaccine Vaxzevria, also known as Covishield, worldwide, citing commercial reasons for the decision. Vaxzevria saved millions of lives AstraZeneca, who developed the vaccine with Oxford University, said it was “incredibly proud of the role Vaxzevria played in ending the global …

AstraZeneca: What are the rare side effects of the Covid jab?
10 months, 1 week ago

AstraZeneca: What are the rare side effects of the Covid jab?

The Independent  

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Get our free Health Check email SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy AstraZeneca has announced it initiated a worldwide withdrawal of its Covid-19 …

AstraZeneca's Covishield Showed Lowest Incidence of Side Effects in India Versus Globally, Says Top Govt Official
10 months, 1 week ago

AstraZeneca's Covishield Showed Lowest Incidence of Side Effects in India Versus Globally, Says Top Govt Official

News 18  

AstraZeneca’s vaccine has demonstrated the lowest incidence of side effects in India compared to the global average, a top government official involved in the national roll-out of Covid-19 vaccination told News18. “But only around 50 cases witnessed Thrombosis with Thrombocytopenia Syndrome — a rare side effect caused by the jab — of the 180 crore doses administered against 4 to …

The truth about AstraZeneca’s Covid vaccine
10 months, 1 week ago

The truth about AstraZeneca’s Covid vaccine

The Independent  

Within 24 hours of my first Covid vaccine, I was in bed, feeling like I had just gone 10 rounds with Mike Tyson. Nonetheless, when it came to the second shot of the Oxford-AstraZeneca Covid vaccine, I was at the front of the queue in the full knowledge of what might happen. Airfinity, a disease forecasting tech company, used that …

After AstraZeneca covid-19 vax recall worldwide, Serum says it stopped manufacturing jabs in Dec 2021
10 months, 1 week ago

After AstraZeneca covid-19 vax recall worldwide, Serum says it stopped manufacturing jabs in Dec 2021

Live Mint  

New Delhi: The Serum Institute of India on Wednesday said it has stopped making and supplying covid-19 vaccine Covishield after AstraZeneca, the British drugmaker that helped develop the vaccine, announced it too was withdrawing its version of the jab worldwide. The development follows the launch of a class action suit in the UK over allegations that the UK vaccine caused …

AstraZeneca withdraws Covid vaccine worldwide after admitting it can cause rare blood clots
10 months, 1 week ago

AstraZeneca withdraws Covid vaccine worldwide after admitting it can cause rare blood clots

The Independent  

The best of Voices delivered to your inbox every week - from controversial columns to expert analysis Sign up for our free weekly Voices newsletter for expert opinion and columns Sign up to our free weekly Voices newsletter Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, …

AstraZeneca pulls its COVID-19 vaccine from the European market
10 months, 1 week ago

AstraZeneca pulls its COVID-19 vaccine from the European market

Associated Press  

LONDON — The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines regulator. In an update on the European Medicines Agency’s website Wednesday, the regulator said that the approval for AstraZeneca’s Vaxzevria had been withdrawn “at the request of the marketing authorization holder.” AstraZeneca’s COVID-19 vaccine was first given …

AstraZeneca begins global withdrawal of Covid-19 vaccines: This is the reason
10 months, 1 week ago

AstraZeneca begins global withdrawal of Covid-19 vaccines: This is the reason

Op India  

On Tuesday, AstraZeneca announced that it has begun the global withdrawal of its COVID-19 vaccine due to a “surplus of available updated vaccines” since the epidemic. “As multiple, variant COVID-19 vaccines have since been developed there is a surplus of available updated vaccines,” AstraZeneca said. AstraZeneca has therefore taken the decision to initiate withdrawal of the marketing authorisations for Vaxzevria …

AstraZeneca withdraws COVID-19 vaccine citing a decline in demand
10 months, 1 week ago

AstraZeneca withdraws COVID-19 vaccine citing a decline in demand

ABC  

In short: Pharmaceutical company AstraZeneca has started a global withdrawal of its COVID-19 vaccine, Vaxzevria, which has not been available in Australia since March 2023. Pharmaceutical company AstraZeneca has started a global withdrawal of its COVID-19 vaccine, Vaxzevria, which has not been available in Australia since March 2023. AstraZeneca has initiated the worldwide withdrawal of its COVID-19 vaccine due to …

Study vaccine, assure people on its safety
10 months, 2 weeks ago

Study vaccine, assure people on its safety

New Indian Express  

Concerns about the safety of Covid vaccines have returned with pharmaceutical giant AstraZeneca admitting that its vaccine, developed in collaboration with Oxford University, can have a rare but serious side effect. Experts say the admission by AstraZeneca, though serious, need not cause panic as it’s a rare side effect, rarer still among Asians and South Americans. A study found 8.1 …

PM Modi's photo removed from vaccine certificates amidst Covishield controversy
10 months, 2 weeks ago

PM Modi's photo removed from vaccine certificates amidst Covishield controversy

Deccan Chronicle  

New Delhi: Amidst the ongoing controversy surrounding the Covishield vaccine, Prime Minister Narendra Modi's photograph has been removed from Covid-19 vaccine certificates. While speculation arose linking this action to AstraZeneca's acknowledgment of rare blood clotting cases associated with the vaccine, official sources have attributed it to the implementation of the election model code of conduct. The court had dismissed a …

AstraZeneca reaffirms Covid vaccine safety amid rare side effect concerns
10 months, 2 weeks ago

AstraZeneca reaffirms Covid vaccine safety amid rare side effect concerns

India TV News  

In response to recent concerns regarding potential rare side effects associated with the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical company has underscored its unwavering commitment to patient safety while affirming the vaccine's overall safety profile. This comes in the wake of a recent admission by AstraZeneca, the pharmaceutical company, that its Covid vaccine Covishield and Vaxzevria "can, in very rare cases, …

In a first, AstraZeneca admits its Covid vaccine can cause rare blood clots
10 months, 2 weeks ago

In a first, AstraZeneca admits its Covid vaccine can cause rare blood clots

The Independent  

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Get our free Health Check email SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy Pharmaceutical giant AstraZeneca has admitted that its widely used Covid vaccine, …

AstraZeneca admits its Covishield vaccine may lead to rare side effect
10 months, 2 weeks ago

AstraZeneca admits its Covishield vaccine may lead to rare side effect

New Indian Express  

As reported by The Telegraph, although AstraZeneca is disputing the allegations, it acknowledged in a legal filing submitted to the High Court in February that the vaccine "can, in very rare instances, lead to TTS." AstraZeneca, in a May 2023 response to Scott's lawyers, contested any direct link between the vaccine and TTS, stating they do not accept such a …

AstraZeneca admits in court that its Covid vaccine can cause rare side-effect ‘TTS’, what is it?
10 months, 2 weeks ago

AstraZeneca admits in court that its Covid vaccine can cause rare side-effect ‘TTS’, what is it?

Hindustan Times  

Pharmaceutical giant AstraZeneca has accepted for the first time that its Covid vaccine “can, in very rare cases, cause TTS”. {{^usCountry}} {{/usCountry}} AstraZeneca has been fighting a class action lawsuit that alleges its Covid vaccine, which was developed with the help of University of Oxford, has led to several deaths and serious injury. {{^userSubscribed}} {{/userSubscribed}} {{^userSubscribed}} {{/userSubscribed}} Responding to Scott's …

UK-Based AstraZeneca Acknowledges Rare Health Risk Of Its Covid Vaccine In Court
10 months, 2 weeks ago

UK-Based AstraZeneca Acknowledges Rare Health Risk Of Its Covid Vaccine In Court

News 18  

UK-based AstraZeneca has acknowledged in court that its Covid vaccine can cause a rare blood clotting condition, British media reports said on Monday. The admission comes amid legal proceedings triggered by claims that the vaccine led to serious health complications, The Daily Mail reported. In a legal document submitted to a UK court in February, the Cambridge-based company conceded that …

AstraZeneca is facing tens of millions of pounds in compensation claims from 35 alleged victims of the Covid jab in High Court legal battle
1 year, 1 month ago

AstraZeneca is facing tens of millions of pounds in compensation claims from 35 alleged victims of the Covid jab in High Court legal battle

Daily Mail  

AstraZeneca is is facing tens of millions of pounds in compensation claims from 35 alleged victims over complications they say were caused by the Covid-19 vaccine. The pharmaceutical giant, which developed its jab in partnership with the University of Oxford, is set to face a High Court battle over claims the vaccine is 'defective' MP Sir Jeremy Wright has been …

AstraZeneca strikes £880m deal to buy US vaccine maker amid questions over Covid jab
1 year, 3 months ago

AstraZeneca strikes £880m deal to buy US vaccine maker amid questions over Covid jab

The Telegraph  

Iskra Reic, executive vice president of vaccines and immune therapies at AstraZeneca, said: “This aligns with our strategy to deliver a portfolio of therapies to address high unmet needs in infectious diseases, and our ambition to protect the most vulnerable patients who have high risk of severe outcomes.” Shares in AstraZeneca rose 1.3pc in afternoon trade on news of the …

AstraZeneca vaccine linked with ‘spike’ in cases of rare disease that can paralyse victims
1 year, 3 months ago

AstraZeneca vaccine linked with ‘spike’ in cases of rare disease that can paralyse victims

The Telegraph  

Scientists have drawn a link between the Oxford-AstraZeneca vaccine and a “spike” in cases of a rare disease that can leave its victims paralysed. Two of the studies looked at rates of GBS in England and said there was an increase in cases “attributable to” the AstraZeneca vaccine, or that there was a probable “causal link”. ‘Side effects ignored’ Anthony …

How safe is AstraZeneca's Covid jab? What rare complications can it cause? Who is taking legal action against the pharma giant? All you need to know
1 year, 4 months ago

How safe is AstraZeneca's Covid jab? What rare complications can it cause? Who is taking legal action against the pharma giant? All you need to know

Daily Mail  

As Brits take AstraZeneca to court we recount what happened with the Covid jab AstraZeneca's Covid vaccine undoubtedly saved millions of lives. AstraZeneca's Covid jab timeline January 2020: Oxford University scientists start working on a Covid vaccine after the World Health Organization declares the spread of the virus a 'Public Health Emergency of International Concern' March 2020: Then Prime Minister …

Is AstraZeneca's Covid jab 'defective'? How firm that supplied 50million doses to the UK could face £90million lawsuit over rare blood clot side effect
1 year, 4 months ago

Is AstraZeneca's Covid jab 'defective'? How firm that supplied 50million doses to the UK could face £90million lawsuit over rare blood clot side effect

Daily Mail  

AstraZeneca said jab has 'acceptable safety profile' and regulators state that the benefits outweigh the risks of 'extremely rare potential side-effects' The jabs were dished out 50million times in the UK during the Covid pandemic The AstraZeneca Covid vaccine has been labelled 'defective' in a multi-million-pound lawsuit by patients who suffered a rare side-effect. IT engineer Jamie Scott suffered a …

Oxford AstraZeneca Covid jab was ‘defective’, claims landmark legal case
1 year, 4 months ago

Oxford AstraZeneca Covid jab was ‘defective’, claims landmark legal case

The Telegraph  

As many as 80 claimants could lodge legal cases with the High Court by the end of the year in a class action that threatens to undermine faith in the rollout of the AstraZeneca vaccine that was developed jointly with Oxford University. In Mr Scott’s claim, his lawyers argue that he suffered “personal injuries and consequential losses arising out of …

AstraZeneca expects ‘minimal’ sales of Covid vaccine this year
2 years, 1 month ago

AstraZeneca expects ‘minimal’ sales of Covid vaccine this year

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails SIGN UP I would like to be emailed about offers, events and updates from The Independent. A year earlier the business sold 1.8 billion US …

Study confirms AstraZeneca jab’s higher risk of very rare clot
2 years, 4 months ago

Study confirms AstraZeneca jab’s higher risk of very rare clot

The Hindu  

AstraZeneca's Covid vaccine has been linked to a 30% higher risk of getting a very rare blood clotting condition compared to the Pfizer jab, a large international study said Thursday. Several countries have already altered their advice after previous research indicated that -- in a tiny number of cases -- thrombosis with thrombocytopenia syndrome can be a possible side effect …

AstraZeneca Covid Jab Linked to 30% Higher Risk of Very Rare Blood Clot: Study
2 years, 4 months ago

AstraZeneca Covid Jab Linked to 30% Higher Risk of Very Rare Blood Clot: Study

News 18  

AstraZeneca’s Covid vaccine has been linked to a 30-percent higher risk of getting a very rare blood clotting condition compared to the Pfizer jab, a large international study said Thursday. Several countries have already altered their advice after previous research indicated that — in a tiny number of cases — thrombosis with thrombocytopenia syndrome can be a possible side effect …

AstraZeneca Covid Booster Shot Effective Against Severe Disease, UK Study Finds
2 years, 10 months ago

AstraZeneca Covid Booster Shot Effective Against Severe Disease, UK Study Finds

News 18  

London: The third dose of AstraZeneca COVID-19 vaccine is effective against symptomatic disease and hospitalisation, offering protection comparable to a booster shot of the Pfizer preventive, according to a study conducted in the UK. The results show that after 25 or more weeks since primary vaccination with AstraZeneca, vaccine effectiveness against symptomatic disease post Omicron infection was 8.0 per cent …

EMA gives green light for AstraZeneca Covid medicine
2 years, 11 months ago

EMA gives green light for AstraZeneca Covid medicine

NL Times  

The European Medicines Agency advised member states to approve AstraZeneca's coronavirus medicine. Pharmaceutical company AstraZeneca previously stated that the drug reduces the risk of coronavirus symptoms or death from Covid-19, both when taken preventively and within three days of developing symptoms. Evusheld consists of two monoclonal antibodies - antibodies counterfeited in the laboratory based on samples from recovering coronavirus patients. …

EU regulator advises AstraZeneca’s COVID drug be cleared
2 years, 11 months ago

EU regulator advises AstraZeneca’s COVID drug be cleared

Associated Press  

LONDON — The European Union’s drug regulator said Thursday it was recommending that an antibody medication developed by AstraZeneca be authorized to help some vulnerable people avoid getting sick with the coronavirus. The agency said it had assessed data on the drug from more than 5,000 people and found Evusheld reduced the risk of infection by 77%, with protection estimated …

AstraZeneca set to abandon push for US vaccine approval
3 years ago

AstraZeneca set to abandon push for US vaccine approval

The Telegraph  

AstraZeneca is braced to abandon efforts to get its Covid vaccine approved in the US if it is simply "banging its head against a brick wall indefinitely" with regulators. Speaking to the Financial Times, he said: “If we don’t end up submitting it for a BLA, I don’t think it will have an impact around the world.” The company has …

Very small blood clot risk after first AstraZeneca Covid shot, say UK studies
3 years ago

Very small blood clot risk after first AstraZeneca Covid shot, say UK studies

India Today  

A large study into rare blood clots linked with AstraZeneca's Covid-19 vaccine found between just one and three cases per million, and only after the first dose, shedding fresh light on the side-effects from the shot. Read: BA.2 sub-variant of Omicron spreads faster, but not more severe, says WHO A study published in the PLOS Medicine journal on Tuesday looked …

Critical AstraZeneca views ‘probably killed hundreds of thousands’ – scientist
3 years, 1 month ago

Critical AstraZeneca views ‘probably killed hundreds of thousands’ – scientist

The Independent  

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, events and updates from The Independent. Please try again later {{ /verifyErrors }} An Oxford …

UK Marks First Anniversary of Oxford-AstraZeneca Covid-19 Vaccine Deployment
3 years, 2 months ago

UK Marks First Anniversary of Oxford-AstraZeneca Covid-19 Vaccine Deployment

News 18  

The UK's health service on Tuesday marked the first anniversary of the deployment of the Oxford/AstraZeneca vaccine against COVID-19, manufactured and deployed in India soon after as Covishield. "Backed by government funding, the UK-made Oxford-AstraZeneca vaccine has played an absolutely crucial role in our fight against COVID-19, saving countless lives in the UK and around the world," said UK Health …

So when WILL Covid chaos end?
3 years, 2 months ago

So when WILL Covid chaos end?

Daily Mail  

Britain could face another year-and-a-half of Covid misery despite a hugely successful vaccination drive, scientists have warned on the back of data showing immunity from booster jabs starts to fade after just 10 weeks. Early real-world analysis of the UK's immunisation scheme shows the efficacy of Pfizer's top-up dose at preventing symptoms drops to as low as 35 per cent …

COVID: Study suggests AstraZeneca booster works against Omicron
3 years, 2 months ago

COVID: Study suggests AstraZeneca booster works against Omicron

Al Jazeera  

Findings from the study, which has yet to be peer reviewed, match those from Pfizer-BioNTech and Moderna. AstraZeneca has said that a third dose of its COVID-19 vaccine “significantly” lifted antibody levels against the Omicron coronavirus variant, citing data from a new laboratory study. Boosters ‘limit Omicron spread’ Oxford’s researchers analysed blood samples taken from individuals infected with COVID-19; those …

AstraZeneca vaccine could be key reason why Britain is weathering the new Covid storm
3 years, 3 months ago

AstraZeneca vaccine could be key reason why Britain is weathering the new Covid storm

The Telegraph  

It is the key question puzzling scientists and commentators – how is Britain managing to weather the latest deadly Covid storm while our European neighbours' defences are crumbling? He suggested that the durability of T-cells from the Oxford/AstraZeneca jab could be keeping older people safer than those on the continent, preventing hospitilisations and deaths even though virus cases are still …

AstraZeneca age group has fewer antibodies against corona, blood bank finds
3 years, 4 months ago

AstraZeneca age group has fewer antibodies against corona, blood bank finds

Dutch News  

People in their early sixties, the age group that was given the AstraZeneca vaccine, have fewer antibodies against coronavirus than other vaccinated groups, according to national blood bank Sanquin. A study of around 1,400 samples from blood donors found that people in the 18 to 25 age group had on average eight times as many antibodies as people aged 61 …

AstraZeneca Asks FDA to Authorise Covid Antibody Treatment
3 years, 5 months ago

AstraZeneca Asks FDA to Authorise Covid Antibody Treatment

News 18  

AstraZeneca, the Anglo-Swedish drugmaker that developed one of the first COVID-19 vaccines, has asked the U.S. Food and Drug Administration to authorise the emergency use of an antibody treatment to prevent the disease. The company said Tuesday that the treatment, known as AZD7442, would be the first long-acting antibody combination to receive an emergency use authorization for COVID-19 prevention. The …

AstraZeneca asks FDA to authorise COVID antibody treatment
3 years, 5 months ago

AstraZeneca asks FDA to authorise COVID antibody treatment

The Hindu  

AstraZeneca, the Anglo-Swedish drugmaker that developed one of the first COVID-19 vaccines, has asked the U.S. Food and Drug Administration to authorise the emergency use of an antibody treatment to prevent the disease. The company said Tuesday that the treatment, known as AZD7442, would be the first long-acting antibody combination to receive an emergency use authorization for COVID-19 prevention. The …

AstraZeneca asks FDA to authorize COVID antibody treatment
3 years, 5 months ago

AstraZeneca asks FDA to authorize COVID antibody treatment

LA Times  

AstraZeneca has asked the Food and Drug Administration to authorize the emergency use of an antibody treatment to prevent COVID-19. AstraZeneca, the drugmaker that developed one of the first COVID-19 vaccines, has asked the U.S. Food and Drug Administration to authorize the emergency use of a first-of-a-kind antibody treatment to prevent the disease. The Anglo-Swedish company said Tuesday that the …

India imposes retaliatory COVID restrictions on British nationals
3 years, 5 months ago

India imposes retaliatory COVID restrictions on British nationals

Al Jazeera  

The move comes after New Delhi called the British decision not to recognise Indian vaccine, Covishield, ‘discriminatory’. Fully vaccinated British nationals arriving in India will be subjected to a 10-day mandatory quarantine, in response to similar measures imposed on Indian nationals. The move comes after India’s Foreign Secretary Harsh Vardhan Shringla called Britain’s decision not to recognise the Indian version …

AstraZeneca Covid-19 vaccine shows 74% efficacy in large US trial
3 years, 5 months ago

AstraZeneca Covid-19 vaccine shows 74% efficacy in large US trial

India Today  

AstraZeneca Plc's Covid-19 vaccine demonstrated 74% efficacy at preventing symptomatic disease, a figure that increased to 83.5% in people aged 65 and older, according to long-awaited results of the company's US clinical trial published on Wednesday. Overall efficacy of 74% was lower than the interim 79% figure reported by the British drugmaker in March, a result AstraZeneca revised days later …

Worried about getting AstraZeneca? The experts answer your questions
3 years, 6 months ago

Worried about getting AstraZeneca? The experts answer your questions

ABC  

A lot of Australians are still worried about the AstraZeneca vaccine but experts say there is no reason for the vast majority not to get it. Dr Price says those conditions include: Central venous sinus thrombosis Heparin-induced thrombocytopenia with thrombosis, where heparin is the medication Capillary leak syndrome Antiphospholipid syndrome Idiopathic splanchnic vein thrombosis Polysorbate 80 anaphylaxis Previous thrombocytopenia syndrome …

Clot risk far lower from vaccines than virus: UK study
3 years, 6 months ago

Clot risk far lower from vaccines than virus: UK study

Al Jazeera  

Researchers examined data on 29 million people in England, where concerns have risen after the vaccine-related death of a BBC presenter. Fears over rare cases of clotting conditions have prompted some countries to rule out or limit rollout of the Oxford-developed AstraZeneca jab, with the United Kingdom recommending that healthy people under 40 get alternative vaccines. The study estimated that …

AstraZeneca announces positive results from clinical trial of COVID-19 prevention drug
3 years, 6 months ago

AstraZeneca announces positive results from clinical trial of COVID-19 prevention drug

Firstpost  

This trial has 5,197 participants who had not been exposed and showed a 77-percent reduced risk of developing symptomatic disease with no severe cases recorded. Drug firm AstraZeneca on Friday announced positive results from a trial of a treatment for Covid-19 symptoms. A new trial of 5,197 participants who had not been exposed showed a 77-percent reduced risk of developing …

Pfizer COVID-19 jab declines faster than AstraZeneca: study
3 years, 6 months ago

Pfizer COVID-19 jab declines faster than AstraZeneca: study

The Hindu  

The effectiveness of the Pfizer-BioNTech vaccine against COVID-19 declines faster than that of the AstraZeneca jab, according to a new study published on August 19. "Two doses of Pfizer-BioNTech have greater initial effectiveness against new COVID-19 infections, but this declines faster compared with two doses of Oxford-AstraZeneca," researchers at Oxford University said. It found that "the dynamics of immunity following …

COVID vaccine efficacy wanes, but jabs offer protection: Study
3 years, 6 months ago

COVID vaccine efficacy wanes, but jabs offer protection: Study

Al Jazeera  

Oxford University researchers say efficacy of Pfizer, AstraZeneca weakens 90 days after second dose, but both ‘still doing really well against Delta’ strain. The efficacy of two widely used coronavirus vaccines against the Delta variant weakens within three months of inoculation, but the jabs remain the most effective way to ensure protection against the strain, Oxford University researchers have found. …

Surge in COVID jabs for young people in NSW and Victoria as vaccines become more available
3 years, 7 months ago

Surge in COVID jabs for young people in NSW and Victoria as vaccines become more available

ABC  

Young Australians in locked-down cities are rolling up their sleeves in massive numbers to protect themselves with the AstraZeneca vaccine. Unvaccinated younger workers who cannot work from home are continuing to circulate the virus in Sydney, and the NSW government is hoping higher vaccination rates will put downward pressure on the infection curve, as well as reduce the number of …

Discover Related